Akari closes ~$7.6M private placement of ADSs and warrants

Akari Therapeutics Plc

Sold 3,817,553 ADSs and warrants at $1.885/unit to investors including chairman and interim CEO; 212,201 units to close later.
Warrants exercisable for 3 years at $1.76/ADS; insider warrants at $1.79/ADS.
Paid Paulson Investment Co. 8% cash fee and issued placement agent warrants for 332,380 ADSs at $1.885, 5-year term.
Company to file resale registration statement with SEC by June 28, 2024.
Securities issued under Section 4(a)(2) and Regulation D; accredited investors only.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.